MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
OraSure Technologies Total Assets 2011-2026 | OSUR
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets OraSure Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 480 M | 483 M | 444 M | 461 M | 454 M | 349 M | 316 M | 296 M | 208 M | 189 M | 190 M | 184 M | 192 M | 128 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 483 M | 128 M | 312 M |
Quarterly Total Assets OraSure Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 423 M | 445 M | 458 M | 480 M | 464 M | 466 M | 468 M | 483 M | - | 454 M | 459 M | 444 M | 432 M | 429 M | 436 M | 461 M | 456 M | 465 M | 456 M | 454 M | 454 M | 454 M | 454 M | 349 M | 349 M | 349 M | 349 M | 316 M | 316 M | 316 M | 316 M | 296 M | 296 M | 296 M | 296 M | 208 M | 208 M | 208 M | 208 M | 189 M | 189 M | 189 M | 189 M | 190 M | 190 M | 190 M | 190 M | 184 M | 184 M | 184 M | 184 M | 191 M | 192 M | 192 M | 192 M | 128 M | 128 M | 128 M | 128 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 483 M | 128 M | 314 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
25.8 B | $ 20.1 | 1.85 % | $ 10.3 B | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
ICU Medical
ICUI
|
4.2 B | $ 148.85 | -0.79 % | $ 3.63 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
26.7 M | $ 8.57 | 2.15 % | $ 173 M | USA |
 |
Alcon
ALC
|
30.3 B | $ 81.03 | -0.12 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.39 | -1.1 % | $ 246 M | USA |
 |
AtriCure
ATRC
|
609 M | $ 36.9 | -0.14 % | $ 1.73 B | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 66.55 | 0.88 % | $ 3.35 B | USA |
 |
electroCore
ECOR
|
16.1 M | $ 6.6 | -7.04 % | $ 36.4 K | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 10.3 | 3.21 % | $ 421 M | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 8.27 | 2.73 % | $ 171 M | USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 81.34 | 1.21 % | $ 16.2 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 137.49 | 0.91 % | $ 7.33 B | USA |
 |
Harvard Bioscience
HBIO
|
137 M | $ 0.5 | -6.73 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 119.29 | 0.28 % | $ 5.78 B | USA |
 |
Merit Medical Systems
MMSI
|
2.42 B | $ 80.93 | 0.85 % | $ 4.71 B | USA |
 |
Isoray
ISR
|
341 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
931 M | $ 154.21 | 3.5 % | $ 4.81 B | USA |
 |
LeMaitre Vascular
LMAT
|
552 M | $ 84.97 | 1.32 % | $ 1.91 B | USA |
 |
STERIS plc
STE
|
10.1 B | $ 261.9 | 0.02 % | $ 25.8 B | USA |
 |
Intuitive Surgical
ISRG
|
18.7 B | $ 505.17 | -0.47 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
8.33 M | $ 1.81 | -2.96 % | $ 18.5 M |  Israel |
 |
Utah Medical Products
UTMD
|
135 M | $ 61.21 | -0.71 % | $ 222 M | USA |
 |
Nephros
NEPH
|
11.9 M | $ 4.35 | -0.91 % | $ 45.2 M | USA |
 |
Milestone Scientific
MLSS
|
9.8 M | $ 0.29 | -2.67 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.35 B | $ 23.4 | 0.13 % | $ 4.03 B | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 38.77 | -1.61 % | $ 127 M | USA |
 |
Predictive Oncology
POAI
|
4.97 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
59.2 M | $ 13.76 | 0.99 % | $ 661 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 203.2 | 1.05 % | $ 58.5 B | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 150.44 | -3.8 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
5.1 B | $ 256.15 | -0.57 % | $ 37.4 B | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 21.91 | -2.97 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
41.9 M | $ 2.21 | -5.36 % | $ 178 M | USA |
 |
Retractable Technologies
RVP
|
161 M | $ 0.7 | -1.03 % | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
510 M | $ 18.9 | -0.24 % | $ 928 M | USA |
 |
Teleflex Incorporated
TFX
|
7.1 B | $ 104.44 | -0.96 % | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
3.64 B | $ 231.57 | -0.4 % | $ 16.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.75 B | $ 12.47 | 1.63 % | $ 2.53 B | USA |